-
Company Insights
Innovation and Patenting activity of China National Accord Medicines Corporation Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of China National Accord Medicines Corporation Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Thematic Analysis
NewAdvertising Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Advertising has been caught up in the artificial intelligence (AI) frenzy and will be one of the industries most disrupted by AI. Generative AI is reshaping advertisers’ practices through tailored, effective ads and dynamic campaigns that evolve according to consumer response. As a result, the relationship between technology, artists, and brands paying for campaigns will profoundly change over the coming years. There is a real concern that advertisers will divert their money into AI-generated art rather than paying artists and...
-
Macroeconomic Analysis
NewVenezuela PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing and utilities activities contributed 45.9% to the gross value added (GVA) in 2023, followed by wholesale, retail and hotels (24.1%), and construction activities (2.4%), according to GlobalData estimates. According to OPEC, Venezuela has around 303.2 billion barrels of proven crude oil reserves, it produced 716,000 barrels of crude oil per day in 2022.
-
Product Insights
NewLikelihood of Approval Analysis for Low-Grade Glioma
Overview How likely is it that the drugs in Low-Grade Glioma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Low-Grade Glioma Overview Low-grade gliomas are benign grade 1 and grade 2...
-
Product Insights
NewLikelihood of Approval Analysis for Non-Small Cell Lung Carcinoma
Overview How likely is it that the drugs in Non-Small Cell Lung Carcinoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-Small Cell Lung Carcinoma Overview Non-small cell lung carcinoma (NSCLC)...
-
Sector Analysis
NewGreece Beverages Consumption Trends and Forecasts Tracker, Q4 2023
Greece Beverages Market Report Overview The Greece beverages market size was valued at 884.1 million liters (ML) in Q4 2023. According to the European Commission, Greece’s GDP improved in 2023, due to strong tourism and the implementation of the National Recovery and Resilience Plan. The Greece beverages market research report recorded essential data on key products, their categories, and their consumption volume in the country for Q4 2023. Furthermore, the report precisely lists new product launches and highlights the latest...
-
Sector Analysis
NewMethicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
Methicillin-resistant Staphylococcus aureus (MRSA) is a virulent, antibiotic-resistant bacteria that is associated with considerable morbidity and mortality (Vázquez-Sánchez et al., 2022). MRSA can be categorized according to the setting in which the infection was acquired, as either healthcare-associated MRSA (HA-MRSA), which is acquired in hospitals or in nursing homes, or community-associated MRSA (CA-MRSA) (CDC, 2019). MRSA remains highly prevalent due to several factors, including an increased number of immunocompromised and elderly patients, who are particularly vulnerable to infection, an increase...
-
Product Insights
NewLikelihood of Approval Analysis for Complicated Intra-Abdominal Infections
Overview How likely is it that the drugs in Complicated Intra-Abdominal Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Complicated Intra-Abdominal Infections Overview Complicated intra-abdominal infections (cIAIs) are infections that...
-
Thematic Analysis
NewInflation in Medical Devices – Thematic Intelligence
Inflation in Medical Devices Thematic Report Overview Even though COVID-19 vaccines and testing allowed economies and societies to safely reopen, supply-demand imbalance, inflation, recession prospects, market volatility, and geopolitical tensions and conflicts inject instability into the economic recovery and growth prospects. According to GlobalData’s Inflation Impact on the Healthcare Industry Survey (H2 2023), inflation, geopolitical conflicts, and reimbursement constraints may have the greatest negative impact on the medical device industry in 2024. These will have a reciprocal impact on healthcare...